| GC34246-5mg |
|
— |
FTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS
|
0 |
— |
|
|
|
| GC34246-1mg |
|
— |
FTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS
|
0 |
— |
|
|
|
| GC34245-10mg |
|
— |
GTFTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS
|
0 |
— |
|
|
|
| GC34245-5mg |
|
— |
GTFTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS
|
0 |
— |
|
|
|
| GC34245-1mg |
|
— |
GTFTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS
|
0 |
— |
|
|
|
| GC34244-5mg |
|
— |
GLP-1 moiety from Dulaglutide
|
0 |
C149H221N37O49 |
|
|
|
| GC34244-1mg |
|
— |
GLP-1 moiety from Dulaglutide
|
0 |
C149H221N37O49 |
|
|
|
| GC34243-5mg |
|
— |
|
0 |
C73H102N20O20S |
|
|
|
| GC34243-1mg |
|
— |
|
0 |
C73H102N20O20S |
|
|
|
| GC34242-5mg |
|
— |
β-Amyloid (1-42), rat TFA
|
0 |
C199H307N53O59S.C2HF3O2 |
|
|
|
| GC34242-1mg |
|
— |
β-Amyloid (1-42), rat TFA
|
0 |
C199H307N53O59S.C2HF3O2 |
|
|
|
| GC34242-500μg |
|
— |
β-Amyloid (1-42), rat TFA
|
0 |
C199H307N53O59S.C2HF3O2 |
|
|
|
| GC34241-10mg |
|
— |
|
0 |
C71H103N17O28 |
|
|
|
| GC34241-5mg |
|
— |
|
0 |
C71H103N17O28 |
|
|
|
| GC34241-1mg |
|
— |
|
0 |
C71H103N17O28 |
|
|
|
| GC34240-10mg |
|
— |
|
0 |
C110H169N29O32 |
|
|
|
| GC34240-5mg |
|
— |
|
0 |
C110H169N29O32 |
|
|
|
| GC34240-1mg |
|
— |
|
0 |
C110H169N29O32 |
|
|
|
| GC34239-5mg |
|
— |
RNAIII-inhibiting peptide(TFA)
|
0 |
C47H57F3N10O13 |
|
|
|
| GC34239-1mg |
|
— |
RNAIII-inhibiting peptide(TFA)
|
0 |
C47H57F3N10O13 |
|
|
|
